2025 Diabetes Treatment Update: The Dual Potential of Mounjaro and Ozempic
Key diabetes management highlights: Mounjaro, a GLP-1/GIP dual agonist, aids glycemic control, weight loss and cardiovascular health. Ozempic (semaglutide) offers weekly dosing for diabetes and weight; uninsured users can save via copay cards. 2025 brings oral GLP-1s and long-acting insulin.…